These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 9152241)

  • 1. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.
    Osorio Y; Cai S; Hofman FM; Brown DJ; Ghiasi H
    Curr Eye Res; 2004; 29(2-3):145-51. PubMed ID: 15512961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
    Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
    Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
    Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
    J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8
    Jaggi U; Wang S; Tormanen K; Matundan H; Ljubimov AV; Ghiasi H
    Front Immunol; 2018; 9():2895. PubMed ID: 30581441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL; Tumpey TM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
    Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
    Nesburn AB; Ghiasi H; Wechsler SL
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1497-502. PubMed ID: 2167298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of herpes simplex virus glycoprotein K (gK) alters expression of HSV receptors in ocularly-infected mice.
    Allen SJ; Mott KR; Ghiasi H
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2442-51. PubMed ID: 24667863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.
    Hendricks RL; Tumpey TM; Finnegan A
    J Immunol; 1992 Nov; 149(9):3023-8. PubMed ID: 1401927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
    Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
    Ghiasi H; Wechsler SL; Kaiwar R; Nesburn AB; Hofman FM
    J Virol; 1995 Jan; 69(1):334-40. PubMed ID: 7983727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
    Thomas J; Rouse BT
    J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines.
    Ghiasi H; Hofman FM; Wallner K; Cai S; Perng G; Nesburn AB; Wechsler SL
    Vaccine; 2000 Dec; 19(9-10):1266-73. PubMed ID: 11137266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.